Clinical Trial Update: Efficacy and Safety Evaluation Study of SCT800 in Previously Untreated Hemophilia A Patients. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of SCT800 in previously untreated patients with Hemophilia A is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• SCT800

Snippet

Sponsor: Sinocelltech Ltd. | Conditions: Haemophilia A | Phase 3 | Status: RECRUITING